imatinib has been researched along with braco-19 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beltran, M; Cuenca, F; Fletcher, JA; Galesa, K; Gunaratnam, M; Haider, SM; Neidle, S; Reszka, AP; Swank, S | 1 |
| Collie, GW; Gunaratnam, M; Neidle, S; Parkinson, GN; Reszka, AP; Todd, AK | 1 |
2 other study(ies) available for imatinib and braco-19
| Article | Year |
|---|---|
Targeting human gastrointestinal stromal tumor cells with a quadruplex-binding small molecule.
Topics: Base Sequence; Cell Line, Tumor; Cell Proliferation; Computer Simulation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Gastrointestinal Stromal Tumors; Humans; Imides; Models, Chemical; Models, Molecular; Molecular Sequence Data; Molecular Structure; Molecular Weight; Naphthalenes; Phenanthrolines; Proto-Oncogene Mas; Proto-Oncogene Proteins c-kit; RNA, Messenger | 2009 |
A naphthalene diimide G-quadruplex ligand inhibits cell growth and down-regulates BCL-2 expression in an imatinib-resistant gastrointestinal cancer cell line.
Topics: Down-Regulation; Drug Resistance, Neoplasm; G-Quadruplexes; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Imides; Ligands; MCF-7 Cells; Molecular Structure; Naphthalenes; Proto-Oncogene Proteins c-bcl-2 | 2018 |